MCID: VSC003
MIFTS: 55

Visceral Leishmaniasis malady

Category: Infectious diseases

Aliases & Classifications for Visceral Leishmaniasis

About this section

Aliases & Descriptions for Visceral Leishmaniasis:

Name: Visceral Leishmaniasis 11 13
Leishmaniasis, Visceral 39 68
Kala-Azar 11 2
 
Infection by Visceral Leishmaniasis 11
Leishmaniasis Visceral 50

Classifications:



External Ids:

Disease Ontology11 DOID:9146
ICD1030 B55.0, B55.9
ICD9CM32 085.0
SNOMED-CT62 186803007, 48115004
MeSH39 D007898
NCIt45 C34771

Summaries for Visceral Leishmaniasis

About this section
CDC:2 Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. It is classified as a Neglected Tropical Disease (NTD). Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of phlebotomine sand flies. There are several different forms of leishmaniasis in people. The most common forms are cutaneous leishmaniasis, which causes skin sores, and visceral leishmaniasis, which affects several internal organs (usually spleen, liver, and bone marrow).

MalaCards based summary: Visceral Leishmaniasis, also known as leishmaniasis, visceral, is related to hemophagocytic lymphohistiocytosis and malignant histiocytosis. An important gene associated with Visceral Leishmaniasis is IL10 (Interleukin 10), and among its related pathways are RXR and RAR heterodimerization with other nuclear receptor and Glucocorticoid receptor regulatory network. The drugs pentamidine and pentamidine isethionate have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and liver, and related mouse phenotypes are craniofacial and muscle.

Disease Ontology:11 A leishmaniasis that is the most severe form of the disease caused by protozoan parasites of the Leishmania genus, resulting in the infection of the internal organs such as liver, spleen and bone marrow. The symptoms include fever, weight loss, and an enlarged spleen and liver.

Wikipedia:71 Visceral leishmaniasis (VL), also known as kala-azar,black fever, and Dumdum fever, is the most severe... more...

Related Diseases for Visceral Leishmaniasis

About this section

Diseases related to Visceral Leishmaniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 307)
idRelated DiseaseScoreTop Affiliating Genes
1hemophagocytic lymphohistiocytosis31.1IFNG, IL10, TNF
2malignant histiocytosis30.6IFNG, IL4, TNF
3cryoglobulinemia30.4IL10, TLR4, TNF
4primary biliary cirrhosis30.3IL10, SLC11A1, TNF
5systemic lupus erythematosus28.7ALB, IFNG, IL10, IL2, IL4, TLR9
6rheumatoid arthritis28.0FOXP3, IFNG, IL10, IL2, IL4, SLC11A1
7malaria25.7ALB, FOXP3, IFNG, IFNGR1, IL10, IL2
8leishmaniasis12.1
9myoclonus epilepsy10.8IFNG, IL4
10piepkorn karp hickok syndrome10.7IL10, TNF
11eye accommodation disease10.6IFNG, IL10, IL4
12thelaziasis10.6IFNG, IL10, IL4
13pulmonary interstitial glycogenosis10.6IL10, TLR4
14panner disease10.6IFNG, TNF
15visual snow syndrome10.6IL2, IL4
16motor peripheral neuropathy10.6IFNG, IL4
176q terminal deletion syndrome10.6IL10, IL4, TNF
18linitis plastica10.6IL2, TNF
19baetz-greenwalt syndrome10.6IFNG, TNF
20scrub typhus10.6ALB, TNF
21basidiobolomycosis10.6IL10, IL4, TNF
22hernia of ovary and fallopian tube10.6IFNG, IL10, TNF
23paralytic lagophthalmos10.6IL10, IL4, TNF
24dentine erosion10.6IFNG, SLC11A1, TLR4
25gonococcal synovitis10.6IFNG, IL4, TNF
26lymphocytic colitis10.6IFNG, IL4, TNF
27pseudoretinitis pigmentosa10.6IFNG, IL10, TNF
28sensorineural hearing loss10.6IFNG, IL10, TNF
29neurotic excoriation10.6IL10, IL4, TNF
30thomsen and becker disease10.6IFNG, IL2, IL4
31psychologic dyspareunia10.6IFNG, IL10, TNF
32peripheral t-cell lymphoma10.6IL10, IL4, TNF
33renal cell carcinoma 410.6IFNG, IL4, TNF
34progressive relapsing multiple sclerosis10.6IFNG, IL10, IL4
35leukostasis10.6IFNG, IL10, TNF
36atrichia with papular lesions10.6IFNG, IL4, TNF
37adenomatoid tumor10.6IL4, SLC11A1, TLR4
38papillary transitional carcinoma10.5IL10, SLC11A1, TNF
39dementia - subcortical10.5IFNG, IL10, TNF
40gastric dilatation10.5IFNG, IL10, TNF
41bulbospinal polio10.5IFNG, IL2, TLR4
42bile duct signet ring cell carcinoma10.5IFNG, IL10, TNF
43collagen disease10.5IFNG, IL10, IL2
44senile cataract10.5IL10, IL4, TNF
45reproductive system disease10.5IFNG, IL10, TNF
46nevus mucinosis10.5IL10, TLR2
47smooth muscle tumor10.5ALB, IFNG, IL10
48geotrichosis10.5IL10, IL4, TNF
49autoimmune pancreatitis10.5IFNG, TNF
50subacute lymphocytic thyroiditis10.5IL10, IL2, IL4

Graphical network of the top 20 diseases related to Visceral Leishmaniasis:



Diseases related to visceral leishmaniasis

Symptoms & Phenotypes for Visceral Leishmaniasis

About this section

MGI Mouse Phenotypes related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

41 (show all 21)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053828.7FOXP3, IFNG, IL10, IL4, NOS2, TGFB1
2MP:00053698.5ALB, IFNG, IL10, NOS2, TGFB1, TLR2
3MP:00053918.3FOXP3, IFNG, IL10, IL4, NOS2, TGFB1
4MP:00028738.0ALB, FOXP3, IFNG, IL10, IL4, TLR2
5MP:00053887.8FOXP3, IFNG, IL10, IL2, IL4, NOS2
6MP:00053907.5IFNG, IFNGR1, IL10, IL4, NOS2, PGD
7MP:00053897.3FOXP3, IFNG, IFNGR1, IL10, IL2, IL4
8MP:00107717.1FOXP3, IFNG, IFNGR1, IL10, IL4, NOS2
9MP:00020067.1ALB, IFNG, IFNGR1, IL10, IL2, NOS2
10MP:00053797.0ALB, FOXP3, IFNG, IFNGR1, IL10, IL2
11MP:00053866.9FOXP3, IFNG, IFNGR1, IL10, IL2, NOS2
12MP:00053856.7FOXP3, IFNG, IFNGR1, IL10, IL2, NOS2
13MP:00053706.6ALB, FOXP3, IFNG, IFNGR1, IL10, IL2
14MP:00053676.4ALB, FOXP3, IFNG, IFNGR1, IL4, NOS2
15MP:00053786.4EEF2, FOXP3, IFNG, IL10, IL2, IL4
16MP:00053875.6FOXP3, IFNG, IFNGR1, IL10, IL2, IL4
17MP:00053975.5FOXP3, IFNG, IFNGR1, IL10, IL2, IL4
18MP:00053845.4ALB, EEF2, FOXP3, IFNG, IFNGR1, IL10
19MP:00053765.2ALB, FOXP3, IFNG, IFNGR1, IL10, IL2
20MP:00053815.1ALB, FOXP3, IFNG, IFNGR1, IL10, IL2
21MP:00107684.5ALB, EEF2, FOXP3, IFNG, IFNGR1, IL10

Drugs & Therapeutics for Visceral Leishmaniasis

About this section

Drugs for Visceral Leishmaniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 60)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
deoxycholic acidapprovedPhase 4, Phase 34083-44-3222528
Synonyms:
(3α,5β,12α)-3,12-dihydroxycholan-24-oic acid
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
7α-deoxycholic acid
Cholerebic
 
Cholorebic
Degalol
Deoxy-Cholate
Deoxy-Cholic acid
Deoxycholatate
Deoxycholate
Deoxycholatic acid
Deoxycholic acid
Desoxycholsäure
deoxycholate
desoxycholic acid
2
Paromomycinapproved, investigationalPhase 4, Phase 3, Early Phase 1291263-89-4, 7542-37-2165580
Synonyms:
(1R,2R,3S,4R,6S)-4,6-Diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
7542-37-2
84420-34-8
AC1L4WW9
Aminosidin
Aminosidine
Aminosidine, sulfate
C00832
CHEMBL370143
CID165580
Catenulin
Crestomycin
D07467
DB01421
Estomycin
Human .alpha.-1-antitrypsin & Paromomyin
Humatin
Hydroxymycin
Hydroxymycin sulfate
MolPort-002-510-747
Monomycin a
NSC227228
Neomycin E
 
Neomycin e
O-2-Amino-2-deoxy-.alpha.-D-glucopyranosyl-(1->4)-O-[O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1->3)-.beta.D-ribofuranosyl(1->5)]-2-deoxy-D-streptamine
PA1-PA2-PA3-PA4
PAROMOMYCIN
PAROMOMYCIN I, AMMINOSIDIN, CATENULIN, CRESTOMYCIN, MONOMYCIN A, NEOMYCIN E
Paramomycin Sulfate
Paramomycin sulfate
Paramomycin sulphate
Paromomicina
Paromomycin (INN)
Paromomycin (TN)
Paromomycin (complex)
Paromomycin I
Paromomycin i
Paromomycin sulfate Rx346208
Paromomycine
Paromomycinum
Paucimycin
Paucimycinum
R 400
R-400
STOCK1N-08708
Zygomycin a1
catenulin
hATT & Paromomycin
paromomycin
3
Miconazoleapproved, investigational, vet_approvedPhase 4, Phase 3, Phase 2, Phase 1362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4
Lidocaineapproved, vet_approvedPhase 41226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5
Amphotericin Bapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 11181397-89-314956, 5280965
Synonyms:
12633-72-6
1397-89-3
30782-62-8
5-18-10-00525 (Beilstein Handbook Reference)
54482-28-9
8055-20-7
AB00513832
ABLC
AC1L1CN2
AC1L24V6
AC1L70KF
AC1L73U6
AC1NQXTD
AC1NTQ32
AC1NUQG4
AC1NY9JC
AC1O7GCZ
AC1O8FQV
AC1O8PFK
AI3-26528
AMPH-B
AMPH-b
Abelcet
Abelecet
AmBisome (TN)
Ambap1397-89-3
Ambisome
Amfotericina B
Amfotericina B [INN-Spanish]
Ampho-Moronal
Amphocin
Amphomoronal
Amphortericin B
Amphotec
Amphotec (TN)
Amphotericin
Amphotericin .BETA.
Amphotericin B
Amphotericin B (JP15/USP/INN)
Amphotericin B Cholesterol Dispersion
Amphotericin B Colloidal Dispersion
Amphotericin B [USAN:INN:JAN]
Amphotericin B, Lipid-based
Amphotericin B, Streptomyces sp.
Amphotericin-B
Amphotericine B
Amphotericine B [INN-French]
Amphotericinum
Amphotericinum B
Amphotericinum B [INN-Latin]
Amphotherizin
Amphotherizin [German]
Amphotéricine B
Amphozone
BIDD:GT0351
BPBio1_000374
BRN 0078342
BSPBio_000340
C-AmB
C06573
C47H73NO17
CCRIS 5963
CHEBI:2682
CHEMBL1200646
CHEMBL267345
CID10533925
CID10629638
CID10677275
CID14956
CID1972
 
CID352546
CID354192
CID5280965
CID5386092
CID5458486
CID5771695
CID6604295
CID6708817
CID6713692
CID9919339
D00203
DB00681
DivK1c_007045
EINECS 215-742-2
Fungilin
Fungisome
Fungisone
Fungizone
Fungizone (TN)
HMS1569A22
HSDB 3008
HSDB 3008 IAB
Halizon
I06-0257
KBio1_001989
KBio2_000551
KBio2_003119
KBio2_005687
KBioGR_002298
KBioSS_000551
LMPK06000002
LNS-AmB
LS-187721
LS-93
Liposomal Amphotericin B
Liposomal amphotericin b
MLS002702966
MolPort-006-392-260
Mysteclin-F
NCGC00014913
NCGC00090808-01
NCGC00098014-01
NCGC00179595-01
NCI527017
NCI60_004288
NCIStruc1_001042
NCIStruc2_000920
NKTR-024
NS 718
NSC 527017
NSC-527017
NSC527017
Prestwick0_000410
Prestwick1_000410
Prestwick2_000410
Prestwick3_000410
Prestwick_721
SMP1_000302
SMR001566780
SPBio_000715
SPBio_002279
ST50999656
SinuNase
SpecPlus_000949
Spectrum2_000818
Spectrum4_001779
Spectrum_000111
UNII-7XU7A7DROE
amophotericin B
amphotericin B liposomal
amphotericin b
6
MiltefosineapprovedPhase 4, Phase 3, Phase 2, Phase 13458066-85-63600
Synonyms:
1-Hexadecylphosphorylcholine
2-(((Hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethylethanaminium hydroxide, inner salt
3,5-Dioxa-4-phosphaunacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-, hydroxide, inner salt, 4-oxide
4-04-00-01460 (Beilstein Handbook Reference)
58066-85-6
AC1L1GAH
BRN 3690495
Baxter Oncology brand of miltefosine
Baxter brand of miltefosine
C039128
C15H32.C7H17NO4P
CHEBI:125047
CHEMBL125
CID3599
Choline hydroxide, hexadecyl hydrogen phosphate, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt
Choline phosphate, hexadecyl ester, hydroxide, inner salt (6CI)
Choline, hexadecyl hydrogen phosphate, inner salt
D 18506
D-18506
D02494
D18506
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, inner salt
Ethanaminium, 2-(((hexadecyloxy)hydroxyphosphinyl)oxy)-N,N,N-trimethyl-, hydroxide, innner salt
H-1850
HDPC
HMS1922D16
HMS2089J15
HePC
Hexadecyl 2-(trimethyl-.lambda.~5~-azanyl)ethyl hydrogen phosphate
 
Hexadecylphosphocholine
Hexadecylphosphorylcholine
I14-7244
IN1227
Impavido
LS-65132
M-7200
Miltefosin
Miltefosin C
Miltefosina
Miltefosina [INN-Spanish]
Miltefosine
Miltefosine (INN)
Miltefosine [INN:BAN]
Miltefosinum
Miltefosinum [INN-Latin]
Miltex
Miltéfosine
MolPort-003-665-519
Monohexadecylphosphocholine
Monohexadecylphosphorylcholine
NCGC00095169-01
NCGC00095169-02
NCGC00095169-03
NSC605583
Prasfarma brand of miltefosine
SPECTRUM1505329
ST51055612
TF-002
UNII-53EY29W7EC
hexadecyl 2-(trimethylazaniumyl)ethyl phosphate
n-Hexadecylphosphorylcholine
7Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 121402
8Antimony Sodium GluconatePhase 4, Phase 3, Phase 2, Phase 116
9meglumine antimoniatePhase 4, Early Phase 126
10AnthelminticsPhase 4, Phase 3, Phase 2, Phase 1431
11AnestheticsPhase 49001
12Antifungal AgentsPhase 4, Phase 3, Phase 2, Phase 13615
13Anti-Bacterial AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 110884
14Liposomal amphotericin BPhase 4, Phase 3, Phase 2, Phase 1118
15Amphotericin B, deoxycholate drug combinationPhase 4, Phase 315
16Antiparasitic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12127
17Gastrointestinal AgentsPhase 4, Phase 38109
18Cholagogues and CholereticsPhase 4, Phase 3127
19Antiprotozoal AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11986
20
PentamidineapprovedPhase 340100-33-44735
Synonyms:
1,3-BIS(4-AMIDINOPHENOXY)PENTANE
1,3-Bis(4-amidinophenoxy)pentane
1,5-Bis(4-amidinophenoxy)pentane
100-33-4
4, 4'-Diamidinodiphenoxypentane
4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide
4,4'-(Pentamethylenedioxy)dibenzamide
4,4'-(Pentamethylenedioxy)dibenzamidine
4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane
4,4'-Diamidinodiphenoxypentane
4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide
4-10-00-00447 (Beilstein Handbook Reference)
4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide
6823-79-6
AB00053572
AC-12459
AC1L1IU8
AC1Q4YYD
BPBio1_000689
BRN 3159790
BSPBio_000625
BSPBio_001752
Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis- (9CI)
C07420
C19H24N4O2
CCRIS 3825
CHEBI:45081
CHEMBL55
CID4735
D08333
DB00738
EINECS 202-841-0
HMS2089J14
HSDB 7474
KBio3_001252
KBioGR_000879
LS-27566
Lomidine
Lomidine (TN)
MB 800
MB-800
MolPort-001-792-506
NCGC00179034-01
NCGC00179034-02
NCI60_042221
NSC 9921
 
NSC620107
NSC9921
Nebupent
Nebupent (*Isethionate)
Nebupent (as isethionate)
P,P'-(pentamethylenedioxy)dibenzamidine
PENTAM
PENTAMIDINE ISETHIONATE
PNT
Pentacarinat
Pentacarinat (*Isethionate)
Pentacarinat (as isethionate)
Pentam 300
Pentam 300 (*Isethionate)
Pentam 300 (as isethionate)
Pentamide
Pentamidin
Pentamidina
Pentamidina [DCIT]
Pentamidindiisetionat
Pentamidine
Pentamidine (INN)
Pentamidine Isethionate
Pentamidine Isethionate 2-Hydroxy-Ethanesulfonic Acid
Pentamidine [INN:BAN:DCF]
Pentamidine isetionate
Pentamidine mesylate
Pentamidinum
Pentamidinum [INN-Latin]
Pneumopent
Prestwick1_000553
Prestwick2_000553
Prestwick3_000553
RP 2512 (*Isethionate)
RP-2512
SPBio_000290
SPBio_002546
Spectrum2_000155
Spectrum3_000276
Spectrum4_000380
Spectrum5_001808
UNII-673LC5J4LQ
WLN: MUYZR DO5OR DYZUM
nchembio873-comp32
p,p'-(Pentamethylene-dioxy)bis-benzamidine
p,p'-(Pentamethylenedioxy)bis[benzamidine]
p,p'-(Pentamethylenedioxy)dibenzamidine
pentamidine
21
Vitamin Eapproved, nutraceutical, vet_approvedPhase 340659-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
22VitaminsPhase 35095
23Aluminum sulfatePhase 2, Phase 387
24Adjuvants, ImmunologicPhase 2, Phase 32484
25VaccinesPhase 2, Phase 3, Phase 16428
26TocotrienolsPhase 3402
27TocopherolsPhase 3406
28TocopherolNutraceuticalPhase 3406
29TocotrienolNutraceuticalPhase 3402
30AntibodiesPhase 1, Phase 26045
31Soybean oil, phospholipid emulsionPhase 273
32ImmunoglobulinsPhase 1, Phase 26045
33Fat Emulsions, IntravenousPhase 292
34Parenteral Nutrition SolutionsPhase 2153
35Pharmaceutical SolutionsPhase 27793
36Soy BeanNutraceuticalPhase 2535
37ThromboplastinPhase 160
38
Acetylcysteineapproved316616-91-112035
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercapturic acid
2-Acetylamino-3-mercapto-propionate
2-Acetylamino-3-mercapto-propionic acid
ACC
Acetadote
Acetilcisteina
Acetylcysteine
Acetylcysteinum
Fluimicil Infantil
Fluimucetin
Fluimucil
Flumucetin
 
Fluprowit
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionic acid
Lysox
Mercapturic acid
Mucolysin
Mucomyst
N-ACETYL-L-cysteine
N-Acety-L-Cysteine
N-Acetyl-3-mercaptoalanine
N-Acetyl-L-(+)-cysteine
N-Acetylcysteine
N-acetylcysteine
NAC
Parvolex
Sodium 2-acetamido-3-mercaptopropionate
39
Coal tarapproved1918007-45-2
Synonyms:
 
Coal tars
Tar, coal
40
Neomycinapproved, vet_approved481404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
 
Framygen
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
41
Albendazoleapproved, vet_approved8054965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
42
Ironapproved11237439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
43
Zincapproved22317440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
44
Erythromycinapproved, vet_approved95114-07-812560
Synonyms:
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
,10-dione
114-07-8
3''-O-demethylerythromycin
374700-25-1
45673_FLUKA
45674_FLUKA
79235-06-6
82343-12-2
A/T/S
AC-12744
AC1L1FIQ
AC1L1QK7
AC1L1ZUR
AC1O8PVA
AC1Q2UA1
AC1Q6O1S
AI3-50138
AR-1A4414
AR-1H0723
Abboticin
Abomacetin
Acneryne
Acnesol
Ak-Mycin
Ak-mycin
Akne Cordes Losung
Akne-Mycin
Akne-mycin (TN)
Aknederm Ery Gel
Aknemycin
Aknin
AustriaS
BB_NC-1332
BIDD:GT0017
BPBio1_000312
BSPBio_000282
BSPBio_002480
Benzamycin
Benzamycin Pak
Bristamycin
C-Solve-2
C01912
C37H67NO13
CCRIS 9078
CHEBI:42355
CHEMBL532
CID12560
CID3255
CID6713919
CID8233
D00140
DB00199
Del-Mycin
Derimer
Deripil
DivK1c_000294
DivK1c_000397
DivK1c_000702
Dotycin
Dumotrycin
E- mycin, Erycin, Robimysin
E-Base
E-Base (base)
E-Glades
E-Mycin
E-Mycin (base)
E-Solve 2
E0751
E0774_SIAL
E5389_SIGMA
E6376_SIAL
E7904_SIGMA
EINECS 204-040-1
EM
EMU
ERY
ERYC
ERYC (base)
ERYTHROMYCIN STEARATE
ETS
Emgel
Emu-V
Emu-Ve
Emuvin
Emycin
Endoeritrin
Erecin
Erimycin-T
Erisone
Eritomicina
Eritrocina
Eritromicina
Eritromicina [INN-Spanish]
Ermycin
Eros
Ery-B
Ery-Diolan
Ery-Sol
Ery-Tab
Ery-Tab (base)
Ery-maxin
Eryacne
Eryacnen
Eryc
Eryc (TN)
Eryc 125
Eryc Sprinkles
Eryc-125
Eryc-250
Erycen
Erycette
Erycin
Erycinum
Eryderm
Erydermer
Erygel
Erygel (TN)
Eryhexal
Erymax
Erymed
Erypar
Erysafe
Erytab
Erythra-Derm
Erythro
Erythro-Statin
Erythro-Teva
Erythrocin
Erythrocin Stearate
Erythroderm
Erythrogran
Erythroguent
Erythromast 36
Erythromid
Erythromycin
Erythromycin & VRC3375
Erythromycin (JP15/USP/INN)
 
Erythromycin A
Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279
Erythromycin B
Erythromycin C
Erythromycin Lactate
Erythromycin Ointment
Erythromycin Stearate
Erythromycin [INN:BAN:JAN]
Erythromycin base
Erythromycin estolate
Erythromycin ethylsuccinate
Erythromycin glucoheptonate
Erythromycin intravenous
Erythromycin lactobionate
Erythromycin oxime
Erythromycin sodium lauryl sulfate
Erythromycin, compd. with monododecyl sulfate, sodium salt
Erythromycine
Erythromycine [INN-French]
Erythromycinum
Erythromycinum [INN-Latin]
Erytop
Erytrociclin
Ethril 250
HMS1568O04
HMS1920M04
HMS2091D05
HMS500O16
HSDB 3074
I06-0245
IDI1_000294
IDI1_000397
IDI1_000702
Ilocaps
Ilosone
Ilosone (estolate)
Iloticina
Ilotycin
Ilotycin Gluceptate
Ilotycin T.S
Ilotycin T.S.
Inderm
Inderm Gel
IndermRetcin
KBio1_000294
KBio1_000397
KBio1_000702
KBio2_000555
KBio2_001139
KBio2_003123
KBio2_003707
KBio2_005691
KBio2_006275
KBioGR_001175
KBioSS_000555
KBioSS_001139
KST-1A8261
Kesso-Mycin
LMPK04000006
LS-187077
LS-64648
Latotryd
Lederpax
MLS001066618
Mephamycin
Mercina
MolPort-000-772-161
MolPort-002-507-378
MolPort-003-933-429
N-Methylerythromycin A
NCGC00179619-01
NCI-C55674
NINDS_000294
NINDS_000397
NINDS_000702
NSC 55929
NSC55929
Oftalmolosa Cusi Eritromicina
Oftamolets
PCE Dispertab (base)
Paediathrocin
Pantoderm
Pantodrin
Pantomicina
Pce
Pce (TN)
Pfizer-e
Pharyngocin
Prestwick0_000151
Prestwick1_000151
Prestwick2_000151
Prestwick3_000151
Prestwick_205
Primacine
Propiocine
Proterytrin
R-P Mycin
Retcin
Robimycin
Romycin
SBB057401
SMP1_000119
SMR000544946
SPBio_000778
SPBio_001226
SPBio_002221
SPECTRUM1500280
STK249736
Sans-acne
Sansac
Serp-AFD
Skid Gel E
Spectrum2_000759
Spectrum2_001263
Spectrum4_000538
Spectrum5_001596
Spectrum_000115
Spectrum_000659
Staticin
Staticin (TN)
Stiemicyn
Stiemycin
Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin
T-Stat
T-stat (TN)
Taimoxin-F
Theramycin Z
Tiloryth
Tiprocin
Torlamicina
UNII-63937KV33D
Udima Ery Gel
Wemid
Wyamycin S
adecane-2,10-dione (non-preferred name)
bmse000664
erythro
erythromycin
nchembio.285-comp13
érythromycine
45
Vitamin Aapproved, nutraceutical, vet_approved46811103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
46Respiratory System Agents4818
47Antioxidants2928
48Expectorants388
49Antidotes1038
50Antiviral Agents9732

Interventional clinical trials:

(show top 50)    (show all 53)
idNameStatusNCT IDPhase
1Amphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenCompletedNCT01032187Phase 4
2Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral LeishmaniasisCompletedNCT00604955Phase 4
3A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL)CompletedNCT01975051Phase 4
4Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in IndiaCompletedNCT01661296Phase 4
5Single Dose Liposomal Amphotericin B for Visceral LeishmaniasisNot yet recruitingNCT01566552Phase 4
6Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in BrazilTerminatedNCT01310738Phase 4
7To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala AzarCompletedNCT00876824Phase 3
8An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral LeishmaniasisCompletedNCT00629031Phase 3
9Combination Therapy in Indian Visceral LeishmaniasisCompletedNCT00523965Phase 3
10Single Infusion of Liposomal Amphotericin B in Indian Visceral LeishmaniasisCompletedNCT00628719Phase 3
11Safety and Efficacy Study of Paromomycin to Treat Visceral LeishmaniasisCompletedNCT00216346Phase 3
12Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral LeishmaniasisCompletedNCT00696969Phase 3
13Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort StudyCompletedNCT01360762Phase 3
14Replacement of Insecticides to Control Visceral Leishmaniasis (VL)CompletedNCT01644682Phase 3
15Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V LeishmaniasisCompletedNCT00255567Phase 3
16Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in BangladeshCompletedNCT01122771Phase 3
17Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With no Response to LeishmaninCompletedNCT00429715Phase 2, Phase 3
18Safety/Efficacy Trial of Killed Leishmania Vaccine in Volunteers With Positive Response to Leishmanin (LST>0)CompletedNCT00429780Phase 2, Phase 3
19Miltefosine for Children With PKDLRecruitingNCT02193022Phase 3
20Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.Active, not recruitingNCT02011958Phase 3
21A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-AzarCompletedNCT00497601Phase 2
22Combination Chemotherapy for the Treatment of Indian Kala-AzarCompletedNCT00370825Phase 2
23Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azarCompletedNCT00371995Phase 2
24A Study Evaluating Sitamaquine Compared With Amphotericin B In The Treatment Of Visceral Leishmaniasis.CompletedNCT00381394Phase 2
25Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern AfricaCompletedNCT01067443Phase 2
26Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern AfricaCompletedNCT02431143Phase 2
27Sodium Stibogluconate Treatment of LeishmaniasisCompletedNCT00662012Phase 2
28Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)CompletedNCT01635777Phase 2
29A Study of a New Leishmania Vaccine Candidate ChAd63-KHRecruitingNCT02894008Phase 2
30Use of Sodium Stibogluconate as a Treatment for LeishmaniasisEnrolling by invitationNCT00657618Phase 1, Phase 2
31Thermotherapy + a Short Course of Miltefosine for the Treatment of Uncomplicated Cutaneous Leishmaniasis in the New World¨Not yet recruitingNCT02687971Phase 2
32Miltefosine for Brazilian Visceral LeishmaniasisTerminatedNCT00378495Phase 1, Phase 2
33Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in SudanTerminatedNCT01980199Phase 2
34Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VLTerminatedNCT00832208Phase 2
35SCH708980 With and Without AmBisome for Visceral LeishmaniasisWithdrawnNCT01437020Phase 1, Phase 2
36Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in IndiaCompletedNCT00486382Phase 1
37Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult VolunteersCompletedNCT02071758Phase 1
38Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDLCompletedNCT00982774Phase 1
39Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult VolunteersCompletedNCT01484548Phase 1
40Immune Response of Visceral Leishmaniasis PatientsTreated With Antimonial Plus N-AcetylcysteineUnknown statusNCT01138956
41A Pilot Study for Capacity Building for a Multi-centre, Randomized Trial for Treatment of Kala Azar in BangladeshCompletedNCT01240473
42Visceral Leishmaniasis and Malnutrition in Amhara Regional State, EthiopiaCompletedNCT02148822
43Efficacy, Acceptability and Cost-effectiveness of Long Lasting Insecticide Nets (LLIN) in the Prevention of Kala AzarCompletedNCT00318721
44Amphotericin B Treatment in Visceral LeishmaniasisCompletedNCT00310505
45Immunogenetics of Visceral LeishmaniasisCompletedNCT00342823
46An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in BangladeshCompletedNCT01328457
47A Community Trial for Visceral Leishmaniasis (VL)CompletedNCT01069198
48Clinical Investigation of Infections Due to Leishmanial ParasitesCompletedNCT00001169
49Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830
50Efficacy of Topical Liposomal Form of Drugs in Cutaneous LeishmaniasisCompletedNCT01050777Early Phase 1

Search NIH Clinical Center for Visceral Leishmaniasis

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: leishmaniasis, visceral

Genetic Tests for Visceral Leishmaniasis

About this section

Anatomical Context for Visceral Leishmaniasis

About this section

MalaCards organs/tissues related to Visceral Leishmaniasis:

36
Bone, Bone marrow, Liver, Spleen, Testes, Skin, T cells

Publications for Visceral Leishmaniasis

About this section

Articles related to Visceral Leishmaniasis:

(show top 50)    (show all 788)
idTitleAuthorsYear
1
Scoring clinical signs can help diagnose canine visceral leishmaniasis in a highly endemic area in Brazil. (28076469)
2017
2
Adenosine generated by ectonucleotidases modulates the host immune system during visceral leishmaniasis. (28082236)
2017
3
Diagnosis of Mediterranean visceral leishmaniasis by detection of Leishmania-related antigen in urine and oral fluid samples. (28017861)
2017
4
Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c mice. (28064069)
2017
5
Comparative genomics of canine-isolated Leishmania (Leishmania) amazonensis from an endemic focus of visceral leishmaniasis in Governador Valadares, southeastern Brazil. (28091623)
2017
6
Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme. (28066878)
2017
7
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the field. (28063460)
2017
8
Visceral leishmaniasis triggering (mimicking) macrophage activation syndrome in a patient with adult onset Still disease. (27813355)
2016
9
Therapeutic effect of ursolic acid in experimental visceral leishmaniasis. (27984757)
2016
10
Identification of Visceral Leishmaniasis-Susceptible Areas using Spatial Modelling in Southern Caucasus. (28026905)
2016
11
The effects of increased heme oxygenase-1 on the lymphoproliferative response in dogs with visceral leishmaniasis. (28065450)
2016
12
Survey of feline visceral leishmaniasis in Azarshahr area, north west of Iran, 2013. (27605767)
2016
13
Correction: Canine-Based Strategies for Prevention and Control of Visceral Leishmaniasis in Brazil. (27606898)
2016
14
Thick Smear is a Good Substitute for the Thin Smear in Parasitological Confirmation of Canine Visceral Leishmaniasis. (27162266)
2016
15
Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis. (27645930)
2016
16
Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs. (27624408)
2016
17
Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis. (27614845)
2016
18
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. (27627654)
2016
19
Correlations between peripheral parasite load and common clinical and laboratory alterations in dogs with visceral leishmaniasis. (27664450)
2016
20
Hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis. (27218126)
2016
21
Increasing potential risk for American visceral leishmaniasis in AmapA!, Brazil. (28001227)
2016
22
Treatment of visceral leishmaniasis: anomalous pricing and distribution of AmBisome and emergence of an indigenous liposomal amphotericin B, FUNGISOME. (27605844)
2016
23
Visceral leishmaniasis in immunocompromised: diagnostic and therapeutic approach and evaluation of the recently released IDSA guidelines. (28011960)
2016
24
Occurrence of Lutzomyia longipalpis andhuman and canine cases of visceral leishmaniasis and evaluation of their expansion in the Northwest region of the State of SALo Paulo, Brazil. (27163563)
2016
25
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients. (27186641)
2016
26
The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis. (27148272)
2016
27
Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. (27183429)
2016
28
Visceral Leishmaniasis Patients Display Altered Composition and Maturity of Neutrophils as well as Impaired Neutrophil Effector Functions. (27965662)
2016
29
Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis by reciprocal regulation of host dual-specificity phosphatases. (28013190)
2016
30
IL-18 gene polymorphism in patients with visceral leishmaniasis in East Azarbaijan, Iran. (27605823)
2016
31
Serosurvey for canine visceral leishmaniasis in rural and urban areas of the Brazilian Legal Amazon. (27986490)
2016
32
An rK28-Based Immunoenzymatic Assay for the Diagnosis of Canine Visceral Leishmaniasis in Latin America. (27162270)
2016
33
Xenodiagnosis on dogs with visceral leishmaniasis: Canine and sand fly aspects related to the parasite transmission. (27198788)
2016
34
Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis. (27142329)
2016
35
Pancytopenia caused by visceral leishmaniasis in a patient immunosuppressed after cancer therapy. (27811190)
2016
36
Visceral leishmaniasis in Southern Rio de Janeiro State and the risk of propagation to SALo Paulo State, Brazil. (27192581)
2016
37
Canine Visceral Leishmaniasis in Wild Canines (Fox, Jackal, and Wolf) in Northeastern Iran Using Parasitological, Serological, and Molecular Methods. (28032106)
2016
38
Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, India. (27645786)
2016
39
The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis. (27215734)
2016
40
Comparative B-mode and Doppler renal ultrasonography with histopathological findings in dogs positive for canine visceral leishmaniasis. (27194210)
2016
41
Hemophagocytic Lymphohistiocytosis in Children With Visceral Leishmaniasis. (27171583)
2016
42
Acceptance and potential barriers to effective use of diagnostic tests for visceral leishmaniasis in an urban area in Brazil. (27192596)
2016
43
Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil. (27618920)
2016
44
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study. (27999807)
2016
45
Age structure of owned dogs under compulsory culling in a visceral leishmaniasis endemic area. (27598014)
2016
46
A Subset of Neutrophils Expressing Markers of Antigen Presenting Cells in Human Visceral Leishmaniasis. (27601622)
2016
47
Risk factors, representations and practices associated with emerging urban human visceral leishmaniasis in Posadas, Argentina. (27622625)
2016
48
The challenges on developing vaccine against visceral leishmaniasis. (27598623)
2016
49
Pancytopenia during tyrosine kinase inhibitor treatment - coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report. (27461416)
2016
50
Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis. (27598624)
2016

Variations for Visceral Leishmaniasis

About this section

Expression for genes affiliated with Visceral Leishmaniasis

About this section
Search GEO for disease gene expression data for Visceral Leishmaniasis.

Pathways for genes affiliated with Visceral Leishmaniasis

About this section

Pathways related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 61)
idSuper pathwaysScoreTop Affiliating Genes
19.9TGFB1, TNF
29.8IFNG, IL2, IL4
39.8IFNG, IL2, IL4
4
Show member pathways
9.7IFNG, IL2, TNF
59.7IFNG, TGFB1, TNF
69.7IFNG, IL2, TGFB1
79.7IFNG, IL2, TGFB1
89.6IL10, TLR4, TNF
99.6IFNG, IL10, IL2, IL4
109.5IL10, IL2, IL4, TNF
119.5IL2, TGFB1, TLR4
12
Show member pathways
9.5FOXP3, IL2, IL4
13
Show member pathways
9.4IFNG, IL2, IL4, NOS2
149.4TLR2, TLR4, TNF
159.4IFNG, IL2, NOS2, TNF
169.3IFNG, IL10, IL2, IL4, TNF
179.3IFNG, IL10, IL2, IL4, TNF
18
Show member pathways
9.3IFNG, IL10, IL2, IL4, TNF
199.3IL10, NOS2, TLR4, TNF
209.3IFNG, IL10, TLR9, TNF
21
Show member pathways
9.2IFNG, IL10, IL2, NOS2, TNF
22
Show member pathways
9.2IFNG, IFNGR1, TNF
239.2TLR2, TLR4, TLR9
249.1TGFB1, TLR2, TLR4, TNF
259.1IFNG, IFNGR1, NOS2
269.0FOXP3, IFNG, IL10, IL2, IL4
279.0IFNG, IL10, IL2, IL4, TGFB1, TNF
28
Show member pathways
9.0IFNG, IL10, IL2, IL4, TGFB1, TNF
29
Show member pathways
9.0FOXP3, IFNG, IL2, IL4, TNF
309.0IFNG, IFNGR1, IL10, IL2
318.9IFNG, TGFB1, TLR2, TLR4, TNF
328.9IFNG, NOS2, TLR2, TLR4, TNF
33
Show member pathways
8.9IL2, TLR2, TLR4, TLR9
348.9IFNG, IFNGR1, TGFB1, TNF
35
Show member pathways
8.7IFNG, IFNGR1, NOS2, TLR4
368.7IFNG, IFNGR1, NOS2, TLR4
37
Show member pathways
8.7FOXP3, IFNG, IL10, IL2, TGFB1, TNF
388.7IFNG, IL10, IL2, TGFB1, TLR9, TNF
39
Show member pathways
8.7IFNG, IFNGR1, IL2, IL4, TNF
40
Show member pathways
8.6NOS2, TLR2, TLR4, TLR9, TNF
41
Show member pathways
8.5IFNG, IFNGR1, IL10, IL2, IL4, TNF
428.5IFNG, IL2, IL4, NOS2, TGFB1, TLR4
43
Show member pathways
8.4IFNG, IFNGR1, NOS2, TLR4, TNF
44
Show member pathways
8.4IFNG, IL4, TGFB1, TLR2, TLR4, TLR9
45
Show member pathways
8.4IFNG, IFNGR1, IL10, IL2, IL4, TGFB1
468.4IFNG, IL10, NOS2, TGFB1, TLR2, TLR4
47
Show member pathways
8.3IL2, TGFB1, TLR2, TLR4, TLR9, TNF
488.2IFNG, IL10, TGFB1, TLR2, TLR4, TLR9
49
Show member pathways
7.9IL10, IL2, IL4, TGFB1, TLR2, TLR4
507.9FOXP3, IFNG, IL10, IL2, IL4, TLR2

GO Terms for genes affiliated with Visceral Leishmaniasis

About this section

Cellular components related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:000989710.1IFNG, IL4, TLR4, TNF
2extracellular spaceGO:00056158.2ALB, IFNG, IL10, IL2, IL4, TGFB1

Biological processes related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

(show top 50)    (show all 77)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of nitric oxide biosynthetic processGO:004501910.8IL10, IL4
2negative regulation of cytokine secretion involved in immune responseGO:000274010.8IL10, TNF
3positive regulation of calcidiol 1-monooxygenase activityGO:006055910.8IFNG, TNF
4regulation of isotype switchingGO:004519110.7IL10, IL4
5positive regulation of killing of cells of other organismGO:005171210.7IFNG, NOS2
6receptor biosynthetic processGO:003280010.7IL10, TNF
7positive regulation of vitamin D biosynthetic processGO:006055710.7IFNG, TNF
8microglial cell activationGO:000177410.7IL4, TLR2
9positive regulation of interleukin-17 productionGO:003274010.7IL2, TGFB1
10positive regulation of interleukin-12 biosynthetic processGO:004508410.6IFNG, TLR4
11macrophage activationGO:004211610.6SLC11A1, TLR4
12negative regulation of growth of symbiont in hostGO:004413010.6IFNG, IL10, TNF
13positive regulation of interleukin-8 biosynthetic processGO:004541610.6TLR4, TNF
14pentose-phosphate shuntGO:000609810.6PGD, TPI1
15positive regulation of chemokine biosynthetic processGO:004508010.5IFNG, IL4, TNF
16negative regulation of interleukin-8 productionGO:003271710.5IL10, TLR9
17positive regulation of isotype switching to IgG isotypesGO:004830410.5IFNG, IL2, IL4
18negative regulation of chronic inflammatory responseGO:000267710.5FOXP3, IL4
19positive regulation of T cell proliferationGO:004210210.5IFNG, IL2, IL4
20negative regulation of T-helper 17 cell differentiationGO:200032010.5FOXP3, IL4
21extrinsic apoptotic signaling pathwayGO:009719110.5IFNG, TGFB1, TNF
22cellular response to lipoteichoic acidGO:007122310.5TLR2, TLR4
23positive regulation of mononuclear cell migrationGO:007167710.4IL4, TGFB1, TNF
24negative regulation of lymphocyte proliferationGO:005067210.4FOXP3, IL2
25defense response to protozoanGO:004283210.4IFNG, IL10, IL4, SLC11A1
26response to molecule of bacterial originGO:000223710.4IL10, TLR9
27positive regulation of nitric oxide biosynthetic processGO:004542910.3IFNG, TLR4, TNF
28positive regulation of interleukin-18 productionGO:003274110.3TLR2, TLR9
29positive regulation of B cell proliferationGO:003089010.3IL2, IL4, TLR4
30regulation of insulin secretionGO:005079610.3IFNG, NOS2, TNF
31positive regulation of toll-like receptor signaling pathwayGO:003412310.3TLR2, TLR9
32positive regulation of interferon-beta biosynthetic processGO:004535910.3TLR4, TLR9
33regulatory T cell differentiationGO:004506610.3FOXP3, TGFB1
34negative regulation of inflammatory responseGO:005072810.2FOXP3, IL10, IL2
35negative regulation of T cell proliferationGO:004213010.2FOXP3, IL10, TGFB1
36positive regulation of MHC class II biosynthetic processGO:004534810.2IFNG, IL10, IL4, TLR4
37response to bacteriumGO:000961710.2NOS2, SLC11A1, TLR4
38positive regulation of protein phosphorylationGO:000193410.2IL2, IL4, TGFB1, TNF
39protein import into nucleus, translocationGO:000006010.1IFNG, SLC11A1, TGFB1, TNF
40positive regulation of regulatory T cell differentiationGO:004559110.1FOXP3, IL2, TGFB1
41negative regulation of interferon-gamma productionGO:003268910.1FOXP3, IL10, TLR4
42negative regulation of tumor necrosis factor productionGO:003272010.1FOXP3, IL10, TLR4
43regulation of interferon-gamma-mediated signaling pathwayGO:006033410.1IFNG, IFNGR1
44tolerance induction to self antigenGO:000251310.1FOXP3, TGFB1
45type 2 immune responseGO:004209210.1IL10, IL4
46positive regulation of interferon-gamma productionGO:003272910.0IL2, SLC11A1, TLR4, TNF
47positive regulation of JNK cascadeGO:004633010.0TLR4, TLR9, TNF
48I-kappaB phosphorylationGO:000725210.0TLR2, TLR4, TLR9
49MyD88-dependent toll-like receptor signaling pathwayGO:00027559.9TLR2, TLR4, TLR9
50positive regulation of interferon-beta productionGO:00327289.9TLR2, TLR4, TLR9

Molecular functions related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lipopolysaccharide receptor activityGO:00018759.7TLR2, TLR4
2growth factor activityGO:00080839.6IL10, IL2, IL4, TGFB1
3cytokine activityGO:00051259.6IFNG, IL10, IL2, IL4, TGFB1, TNF

Sources for Visceral Leishmaniasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet